Global Esoteric Testing Market 2019-2023

特殊検査の世界市場2019-2023

◆タイトル:Global Esoteric Testing Market 2019-2023
◆商品コード:IRTNTR30903
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年2月23日
◆ページ数:115
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、特殊検査の世界市場について調査・分析し、市場概要、市場環境、特殊検査市場規模、エンドユーザー別(病院検査室、臨床研究所・医療機関、参考検査室)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・特殊検査の世界市場概要
・特殊検査の世界市場環境
・特殊検査の世界市場動向
・特殊検査の世界市場規模
・特殊検査の世界市場:業界構造分析
・特殊検査の世界市場:エンドユーザー別(病院検査室、臨床研究所・医療機関、参考検査室)
・特殊検査の世界市場:地域別市場規模・分析
・特殊検査の北米市場規模・予測
・特殊検査のヨーロッパ・中東・アフリカ市場規模・予測
・特殊検査のアジア太平洋市場規模・予測
・特殊検査の主要国分析
・特殊検査の世界市場:成長要因、課題
・特殊検査の世界市場:競争環境
・特殊検査の世界市場:関連企業情報(ベンダー分析)

About this market
The increasing prevalence of chronic diseases, such as cancers, among individuals is fueling the demand for the early diagnosis of diseases to offer better patient care. Infections are increasingly caused by pathogens such as bacteria, viruses, fungi, and parasites, resulting in diseases such as hepatitis and herpes as well as urinary tract infections and bladder infections. Anatomical pathologists are increasingly performing esoteric testing to investigate and diagnose diseases by examining surgical specimens, including specimens from a biopsy. Thus, the increase in the prevalence of chronic and infectious diseases, coupled with the demand for early diagnoses through esoteric testing, is expected to propel the growth of the global esoteric testing market during the forecast period. Technavio’s analysts have predicted that the esoteric testing market will register a CAGR of almost 12% by 2023.
Market Overview
Increasing industry developments
Vendors are increasingly focusing on improving their distribution networks and ensuring the availability of services to healthcare centers. The increasing developments in esoteric testing are expected to propel the growth of the global esoteric testing market during the forecast period.
Lack of highly skilled professionals
Esoteric testing requires skilled professionals such as pathologists and clinical laboratory scientists who perform esoteric tests for the advanced diagnosis of diseases. However, the lack of adequate training and courses on esoteric testing in emerging economies is one of the prime factors limiting the number of students graduating to perform esoteric tests.
For the detailed list of factors that will drive and challenge the growth of the esoteric testing market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fairly concentrated and with the presence of several vendors. The vendors in the global esoteric testing market have adopted various strategies, including press releases, annual reports, and participation in conferences, to promote their product offerings. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Hospital laboratories – Market size and forecast 2018-2023
• Clinical research laboratories and medical institutes – Market size and forecast 2018-2023
• Reference laboratories – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Technological advances in molecular diagnostics
• Advances in genomics and proteomics
• Improving healthcare infrastructure in emerging economies
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Enzo Biochem Inc.
• Eurofins Scientific
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Sonic Healthcare
PART 13: APPENDIX
• Research methodology
• List of abbreviations


Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 08: Global market
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: End-user – Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Hospital laboratories – Market size and forecast 2018-2023 ($ billions)
Exhibit 20: Hospital laboratories – Year-over-year growth 2019-2023 (%)
Exhibit 21: Clinical research laboratories and medical institutes – Market size and forecast 2018-2023 ($ billions)
Exhibit 22: Clinical research laboratories and medical institutes – Year-over-year growth 2019-2023 (%)
Exhibit 23: Reference laboratories – Market size and forecast 2018-2023 ($ billions)
Exhibit 24: Reference laboratories – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ billions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ billions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ billions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ billions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Enzo Biochem Inc. – Vendor overview
Exhibit 46: Enzo Biochem Inc. – Business segments
Exhibit 47: Enzo Biochem Inc. – Organizational developments
Exhibit 48: Enzo Biochem Inc. – Geographic focus
Exhibit 49: Enzo Biochem Inc. – Segment focus
Exhibit 50: Enzo Biochem Inc. – Segment focus
Exhibit 51: Enzo Biochem Inc. – Key offerings
Exhibit 52: Eurofins Scientific – Vendor overview
Exhibit 53: Eurofins Scientific – Product segments
Exhibit 54: Eurofins Scientific – Organizational developments
Exhibit 55: Eurofins Scientific – Segment focus
Exhibit 56: Eurofins Scientific – Key offerings
Exhibit 57: Laboratory Corporation of America Holdings – Vendor overview
Exhibit 58: Laboratory Corporation of America Holdings – Business segments
Exhibit 59: Laboratory Corporation of America Holdings – Organizational developments
Exhibit 60: Laboratory Corporation of America Holdings – Geographic focus
Exhibit 61: Laboratory Corporation of America Holdings – Segment focus
Exhibit 62: Laboratory Corporation of America Holdings – Key offerings
Exhibit 63: Quest Diagnostics Incorporated – Vendor overview
Exhibit 64: Quest Diagnostics Incorporated – Business segments
Exhibit 65: Quest Diagnostics Incorporated – Organizational developments
Exhibit 66: Quest Diagnostics Incorporated – Segment focus
Exhibit 67: Quest Diagnostics Incorporated – Key offerings
Exhibit 68: Sonic Healthcare – Vendor overview
Exhibit 69: Sonic Healthcare – Business segments
Exhibit 70: Sonic Healthcare – Organizational developments
Exhibit 71: Sonic Healthcare – Geographic focus
Exhibit 72: Sonic Healthcare – Segment focus
Exhibit 73: Sonic Healthcare – Key offerings
Exhibit 74: Validation techniques employed for market sizing



【掲載企業】

Enzo Biochem Inc.、Eurofins Scientific、Laboratory Corporation of America Holdings、Quest Diagnostics Incorporated、Sonic Healthcare

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[特殊検査の世界市場2019-2023]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆